| 标题 |
Commentary on a Phase III Trial of Bevacizumab plus XELOX or FOLFOX4 for First-Line Treatment of Metastatic Colorectal Cancer: The NO16966 Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Colorectal Cancer 作者:Preeta Tyagi; Axel Grothey 出版日期:2006-11-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)